MOUD Training in Rumford

Presenting by Kristen Silvia, MD

Are you a provider or healthcare staff with an interest in MAT/MOUD? Join us for an 8-hour MOUD training, get professional contact hours/CME, and get your questions answered.

Option to join online mentorship 2x/a month following the training.

Invitation code: WAIVER-225576-11954

Need lodging, travel, or hybrid option? Email: support@rbhwcme.org

Course objectives
At the conclusion of this activity participants should be able to:

Screen and identify patients with OUD and define evidence-based treatments.
Discuss the pharmacology of opioids as it relates to the treatment of opioid use disorder (OUD) patients.
Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
Explain the process of buprenorphine induction as well as stabilization and maintenance.
Discuss all FDA-approved antagonist and agonist medications to treat OUD.
Discuss basic office protocols including medical record documentation and confidentiality.
Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
Recognize the importance of obtaining a waiver to begin treating patients with OUD.

Credits

8 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals

8 Category I contact hours for Maine psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.

8 contact hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.

8 contact hours pending for alcohol and drug counselors from the board of alcohol and drug counselors

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry, Medical Care Development Global Health, and Tri-County Mental Health Services. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this live course for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education
through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to 8 Nursing Contact Hours.

PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

AAAP is the Data Sponsor for this waiver training. pcss@aaap.org.

The Rural Behavioral Health Workforce Center is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,365,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

 Funding for this initiative was made possible in part by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.